HealthSource Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.8/10
Best for: an oral route if you will not self-inject
HealthSource scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on follow-up care. Its compounded semaglutide costs $199 a month, the same as the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
Semaglutide costs $199, billed every 4 weeks. One subscription price buys the medication itself, the supplies, unlimited provider messaging over a HIPAA-compliant platform, and a telehealth visit with a physician who is board-certified. HealthSource sells compounded semaglutide and tirzepatide in two forms, injectable and oral sublingual, dispensed by a partner pharmacy that is US-based and FDA 503A licensed. All 50 US states are served, and direct-to-door delivery takes 3-5 business days.
Is HealthSource legit?
Yes. HealthSource is a real, operating US company, and we found no FDA warning letters issued to it. It says its medication comes from accredited compounding pharmacies (503A, 503B or PCAB). We rate it 7.8/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a HealthSource promo or coupon code?
We know of no promo or coupon code for HealthSource. Its listed price is $199 a month. Coupon sites advertising "HealthSource discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how HealthSource compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to HealthSource
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Luvo Health
Best for: moving between compounded and brand without changing seller
Editorial score · methodology
HealthSource at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Oral Tirzepatide
- Starting price
- $199/mo
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letters found
How HealthSource scores
Six columns, each one computed from something HealthSource has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
5.0/10$199/month is exactly the median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
7.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
10.0/10Serves all 50 states.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on HealthSource
Last checked October 2026- Checked the listed price across 3 dose or plan tiers
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for HealthSource
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with HealthSource involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1HealthSource shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask HealthSource which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits and shipping.
- Lowest ongoing monthly price: semaglutide $199, tirzepatide $299. That leaves out membership fees, first-month rates and insurance copays.
- HealthSource serves all 50 states.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting HealthSource
- Phone
- 212-203-9428
- HealthSource offers email support
Cancelling HealthSource
Taken from the terms HealthSource publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None
- Refund policy
- No refunds once the pharmacy processes a prescription; processed subscription charges are non-refundable
- Early-termination fee
- None
Medications HealthSource lists
HealthSource lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Peptides HealthSource offers
HealthSource sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Pricing
Prices re-verified
$199.00 every 4 weeks for compounded semaglutide with B12 in vials, with syringes and alcohol pads; the same price for Starter 4-week, Starter 6-week and Full Dose. An 8-week supply is $349.00 every 8 weeks.
$299.00 every 4 weeks for injectable tirzepatide from a 503A partner pharmacy, the same across starter and full dose. An 8-week supply is $549.00 every 8 weeks.
$399.00 every 4 weeks for an under-the-tongue tirzepatide tablet used nightly, starter or full dose. Ships in 5–10 business days.
Check the price yourself before you pay
Every figure here comes from HealthSource's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $199 a month, exactly the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $299 a month, close to the $269 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- We found no FDA warning letters issued to HealthSource
Against it
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What HealthSource charges
HealthSource charges $199/month.
- Compounded semaglutide: $199/month
- Compounded tirzepatide (injection): $299/month
- Compounded tirzepatide (sublingual): $399/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so HealthSource's $199 lands mid-market. Price is unlikely to be the deciding factor. Before you pay, compare HealthSource's cancellation terms with other sellers' cancellation and refund policies.
Bodybuilding Health+ dispenses semaglutide and tirzepatide from $179/month, which makes it the fair comparison to run before you commit here.
What HealthSource dispenses
HealthSource prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at HealthSource at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot. No human absorption study of sublingual semaglutide drops has been published.
Safety and disclosure
HealthSource tells you its price before you start the medical questionnaire, that it treats patients in all 50 states, and that its pharmacy is accredited. It also offers clinician messaging between visits. We found no FDA warning letters issued to HealthSource. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If HealthSource will not tell you, treat that as a warning sign. A 503A pharmacy answers to a state board and a 503B facility to the FDA; which one fills it changes what you can check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
HealthSource also sells NAD+, and a 2026 systematic review found no outcomes trials of injected NAD+ for anti-aging or wellness.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether HealthSource bills your plan before you start.
It fits if
- injections are the thing keeping you from starting
- you need access wherever you live
- reaching a clinician between visits matters to you
Our read
HealthSource lands mid-market on price without a standout advantage or an obvious problem. It comes down to whether its particular package fits you. Belle Health is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
HealthSource scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on follow-up care. Its compounded semaglutide costs $199 a month, the same as the $199 median among the sellers we compare.
Before you pay HealthSource
Starting at $199 a month. Check today's price, then start the intake.
Where HealthSource is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to HealthSource sets more sellers in the same category beside HealthSource on price, states and what the price includes.
Frequently Asked Questions
How to check HealthSource yourself
- We Read FDA's Register of Compounding Facilities. 43 of 100 Have Never Been Inspected.
- Buying Tirzepatide as a Research Chemical: What "Research Use Only" Really Means
- Is Ozempic Available Over the Counter? No GLP-1 Is, and What Is Sold Instead
Every seller that ships to your state, side by side: Minnesota, New Mexico, North Carolina, Pennsylvania, Rhode Island, Texas, Vermont, West Virginia and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this HealthSource review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See HealthSource's current pricing
Plans start at $199 a month. Whether you qualify is a clinician's decision, made after your intake.